 UBS Group AG cut its position in shares of Concert Pharmaceuticals Inc NASDAQ:CNCE by 25.0 during the 1st quarter, Holdings Channel.com reports. The firm owned 58,953 shares of the biotechnology companys stock after selling 19,676 shares during the period. UBS Group AGs holdings in Concert Pharmaceuticals were worth 521,000 at the end of the most ... 